6-phenyl-2-[((piperidin-4-ylmethyl)-piperazin-1YL) or piperazin 1-ylmethyl)-piperidin-1-yl)]-imidazo[2,1-B][1,3,4]thiadiazole derivatives and their use

U. Nir (Inventor), Sally Shpungin (Inventor), Etai Yaffe (Inventor), Moshe Cohen (Inventor)

Research output: Patent

Abstract

Heterocyclic compounds of formula (I), (II), (III) or a pharmaceutically acceptable salt thereof: Figure US08653082-20140218-C00001 wherein R1, R2 and R3 are each independently selected from hydrogen, halogen, C1-6alkyl, C2-6alkenyl, N—(C1-6alkyl)2, and N—(C2-6alkenyl)2, the C1-6alkyl and C2-6alkenyl being straight or branched; and Y1 and Y2 are selected from N and CH where one of Y1 and Y2 is N and the other is CH, are provided. Also provided are the synthesis of and pharmaceutical compositions including these compounds. These compounds and pharmaceutical compositions thereof can be used for the treatment of disorders, and in particular, cancer.
Original languageEnglish
Patent numberUS8653082B2
StatePublished - 2014

Bibliographical note

China-patent No. 201080009017.3, EPO-patent No. 10710457.2, USA-patent No. 13/203,172, Israel-patent NO. 214656, France-patent No. 10710457.2, Germany-patent No. 10710457.2, Switzerland- patent No. 10710457.2, UK-patent No. 10710457.2

Fingerprint

Dive into the research topics of '6-phenyl-2-[((piperidin-4-ylmethyl)-piperazin-1YL) or piperazin 1-ylmethyl)-piperidin-1-yl)]-imidazo[2,1-B][1,3,4]thiadiazole derivatives and their use'. Together they form a unique fingerprint.

Cite this